By Business/Source
Currency:JPY
2025/FY
Stock NameRevenueRatio
Pharmaceutical business (Research & Development, purchasing, manufacturing, and sales)486.87B100.00%
By Country/Region
Currency:JPY
2025/FY
Stock NameRevenueRatio
Japan295.25B60.64%
Americas167.05B34.31%
Asia16.34B3.36%
Europe7.5B1.54%
Other729M0.15%
